Corganics® provides scientifically formulated and physician advised, broad-spectrum CBD products with the same quality expected of highest quality medications.
We’re excited about the potential of hemp-based, broad spectrum cannabinoid therapy and will continuously work to expedite its entry into treatment options for healthcare professionals. Our mission is to bridge the gap between healthcare professionals and their patients when it comes to understanding and treating the Endocannabinoid System (ECS).
Up until now, health care professionals have been largely excluded from the conversation about broad spectrum cannabinoid therapy (without detectable THC). We seek to change that by educating and reintegrating health care professionals as a trusted, unbiased source of information on the potential benefits of quality hemp-derived cannabinoid therapy and how it interacts with the Endocannabinoid System (ECS).
Who we are
Corganics® was founded by biotech industry experts Reggie Gatewood and Chad Collins.
Reggie Gatewood, Founder, President
Reggie brings over two decades of commercial sales, marketing, change leadership and large scale training success to Corganics®. During his time as US Head of Sales at Dermik the scale up and highly successful launch of Sculptra Aesthetic in the US marketplace.
Reggie has successfully led sales teams in the biotech, buy-and-bill, medical device and pharmaceutical sectors. Reggie has held multiple roles as a marketer, including spearheading the U.S. launch of a new indication for Plavix, the multi-billion dollar blockbuster cardiovascular medication that became one of the most successful products ever launched.
An International Coaching Federation (ICF) certified life coach with a passion for serving others, Reggie brings decades of experience in science-backed health solutions and working side by side with health care providers.
Like many others, he was drawn to CBD because of its potential to support people’s health naturally and safely. However, Reggie was taken aback by the lack of regulation, quality control, and evidence-based information in the CBD industry.
Given his unique perspective at the interface between patients and their doctors, he saw an opportunity to provide clinical grade CBD products and integrate health care professionals into the conversation about the potential benefits of hemp.
Chad Collins, Founder, CEO
Chad Collins is a visionary, dynamic, and collaborative health care executive with over 20 years of leadership experience in the biopharmaceutical and medical device industries.
Chad's roles have included executive-level general management as well as commercial and operational work involving the responsibility of building multibillion-dollar brands and businesses in the US and throughout North America.
He has taken on leadership positions with large global organizations such as Sanofi, Stryker, and Galderma, plus a successful private health care start-up.
Mr. Collins received an BBA from Texas Tech University, studied executive leadership at Harvard University, and earned an MBA in General Management from the Johnson School of Management at Cornell University.